83 results
424B3
PRTG
Portage Biotech Inc
6 Mar 24
Prospectus supplement
9:36pm
scientific oversight Lean structure with financial flexibility Preferred Partner for Pharma in I/O Deep industry network facilitates engagement with big
6-K
EX-99.1
PRTG
Portage Biotech Inc
6 Mar 24
Current report (foreign)
9:11pm
Preferred Partner for Pharma in I/O Deep industry network facilitates engagement with big pharma and biotech Packaged for commercialization
424B3
PRTG
Portage Biotech Inc
28 Feb 24
Prospectus supplement
5:19pm
deducting placement agent’s fees and estimated offering expenses of approximately $0.7 million.
Pursuant to an engagement letter, dated as of August 26 … to an engagement letter, dated as of August 26, 2023, between the Company and the “Placement Agent, the Company paid the Placement Agent a total cash fee equal
6-K
EX-99.1
PRTG
Portage Biotech Inc
28 Feb 24
Current report (foreign)
5:17pm
to an engagement letter, dated as of August 26, 2023, between the Company and H.C. Wainwright & Co., LLC (the “Placement Agent”), the Company paid … offering expenses.
Pursuant to an engagement letter, dated as of August 26, 2023, between the Company and the “Placement Agent, the Company paid
6-K
EX-99.2
PRTG
Portage Biotech Inc
28 Feb 24
Current report (foreign)
5:17pm
of extracellular adenosine. Engagement with adenosine receptors type 2A (“A2A”) and type 2B (“A2B”) triggers a dampening effect on the immune … deducting placement agent’s fees and estimated offering expenses.
Pursuant to an engagement letter, dated as of August 26, 2023, between us and H.C
424B3
ub4q yd9g00o0myol212
18 Jan 24
Prospectus supplement
5:41pm
6-K
EX-99.1
3njopc3v4nn
18 Jan 24
Current report (foreign)
5:09pm
424B3
0iq2cu 98
28 Nov 23
Prospectus supplement
4:03pm
6-K
EX-99.1
wpjo9wu c3
28 Nov 23
Current report (foreign)
4:01pm
6-K
EX-99.2
5s4ia2d
28 Nov 23
Current report (foreign)
4:01pm
424B3
6ob x1jm4dx7i
14 Nov 23
Prospectus supplement
6:00am
6-K
EX-99.1
9xsr5
13 Nov 23
Current report (foreign)
6:10am
424B3
hbe9a9xlw0a5mdz
7 Nov 23
Prospectus supplement
4:50pm
F-1
EX-5.1
rz8dk iabkurh5018xe
31 Oct 23
Registration statement (foreign)
4:05pm
F-1
k3u0ig6yxdpo2qld
31 Oct 23
Registration statement (foreign)
4:05pm
6-K
dq1ifmqhzuvdi5wx
3 Oct 23
Current report (foreign)
4:05pm
6-K
EX-4.5
7as57f4 z4jqi
3 Oct 23
Current report (foreign)
4:05pm
424B5
625meymhlritzsnpd760
2 Oct 23
Prospectus supplement for primary offering
6:01pm
6-K
EX-99.1
cci r0jh9
8 Sep 23
Current report (foreign)
4:01pm
6-K
EX-99.2
aepk7wncy0x2 wi4
29 Aug 23
Current report (foreign)
4:01pm